kontakt@femireform.se 0768535782 Kungsgatan 111 Vån 2 Kungshörnet. Klövern, 75318 Uppsala
Info & studier

ISSN: ISSN 1855-9913 Ursp. publicerad: Journal of the Laser and Health Academy Vol. 2012, No.1; www.laserandhealth.com


Zdenko Vizintin1, Mario Rivera2, Ivan Fistonić3, Ferit Saraçoğlu4, Paolo Guimares5, Jorge Gaviria6, Victor Garcia7, Matjaz Lukac8, Tadej Perhavec1, Leonardo Marini9


The intent of this Laser and Health Academy publication is to facilitate an exchange of<br />information on the views, research results, and clinical experiences within the medical<br />laser community. The contents of this publication are the sole responsibility of the<br />authors and may not in any circumstances be regarded as official product<br />information by medical equipment manufacturers. When in doubt, please check with<br />the manufacturers about whether a specific product or application has been approved<br />or cleared to be marketed and sold in your country.

Forskningsstudie 2: Novel Minimally Invasive VSP Er:YAG Laser Treatments in Gynecology

Novel Minimally Invasive VSP Er:YAG Laser Treatments in GynecologyLaser Vaginal


Some of the most common health problems amongwomen that are caused by a deteriorating laxity, elasticityand tightness of mucous membranes are vaginalrelaxation (and the associated loss of sexual gratification) and stress urinary incontinence. Recently, two novel minimally invasive, non-ablative Er:YAG laser techniques have been introduced, a vaginal tightening therapy IntimaLaseTM and a stress urinary incontinence therapy IncontiLaseTM, which show the potential to become an optimal solution for many women suffering from these problems. Both treatment techniques exploit the photothermal effect of a laser beam on mucosa tissue in order to cause its shrinkage without any removal of tissue. The overall impact and burden on the patient's organism is thus minimal, as opposed to more invasive classical or laser surgical procedures. In this paper, a special Er:YAG Pixel Screen technology used in these novel gynecological treatments, and its ablative characteristics, are first analyzed w ith t he a im t o e stablish a r ange o f l aser parameters for safe, single-pulse or SMOOTH mode, non-ablative treatment of mucosa tissue. The initial results of multi-center clinical studies of the IntimaLaseTM and IncontiLaseTM treatments are then presented. All five centers involved in the studies of the IntimaLaseTM treatment reported positive results, i.e an improvement in vaginal tightness for a large majority of treated patients, with practically no adverse effects. Similarly, all four studies of the IncontiLaseTM treatment showed improvement in stress urinary incontinence (SUI) for a large majority of treated patients. Many patients with mild SUI reported to become free of the symptoms of incontinence following the treatment. There were no adverse effects of this treatment reported in any of the studies. Based on these initial clinical results, the new IntimaLaseTM and IncontiLaseTM gynecological treatments are promising to become a minimally invasive solution of choice for many women suffering from vaginal relaxation syndrome or stress urinary incontinence. Key words: Er:YAG laser; vaginal relaxation, stress urinary incontinence (SUI), mucosa ablation, pixel screen technology, Smooth mode.Article: J. LAHA, Vol. 2012, No.1; pp.46-58.Received: April 25, 2012; Accepted: May 07, 2012.© Laser and Health Academy. All rights reserved.Printed in Europe. www.laserandhealth.com